Exhibit 12.2
Certification
Pursuant to Section 302
The Sarbanes-Oxley Act of 2002
I, Gabrielle Heaton, certify that:
| 1. | I have reviewed this Annual Report on Form 20-F/A for the fiscal year ended June 30, 2017 (‘Report’) of Kazia Therapeutics Limited (formerly known as Novogen Limited) (the ‘Company’); |
| 2. | Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report; |
| /s/ Gabrielle Heaton |
Gabrielle Heaton Director of Finance and Administration |
Date: December 18, 2017
